北京嘉林藥業股份有限公司

北京(jing)(jing)嘉林藥業股(gu)份(fen)(fen)有(you)限(xian)(xian)公(gong)(gong)司(si)成(cheng)(cheng)(cheng)立于1998年(nian)12月，是(shi)北京(jing)(jing)市(shi)(shi)科(ke)委(wei)任命的(de)高新(xin)技術(shu)(shu)企(qi)業，是(shi)上(shang)市(shi)(shi)公(gong)(gong)司(si)德(de)展大健康股(gu)份(fen)(fen)有(you)限(xian)(xian)公(gong)(gong)司(si)的(de)全資(zi)子公(gong)(gong)司(si)。現(xian)躋身2016年(nian)度中(zhong)國(guo)制(zhi)藥工業百強榜前50名(ming)。2000年(nian)12月，經北京(jing)(jing)市(shi)(shi)人(ren)(ren)民政府批準，公(gong)(gong)司(si)進行股(gu)份(fen)(fen)制(zhi)改造。2005年(nian)10月，公(gong)(gong)司(si)名(ming)稱由北京(jing)(jing)紅惠(hui)生物(wu)(wu)制(zhi)藥股(gu)份(fen)(fen)有(you)限(xian)(xian)公(gong)(gong)司(si)更名(ming)為(wei)(wei)北京(jing)(jing)嘉林藥業股(gu)份(fen)(fen)有(you)限(xian)(xian)公(gong)(gong)司(si)。公(gong)(gong)司(si)重(zhong)點(dian)產品相繼(ji)列入(ru)國(guo)家重(zhong)點(dian)火炬計劃(hua)、國(guo)家重(zhong)點(dian)新(xin)產品計劃(hua)、北京(jing)(jing)市(shi)(shi)重(zhong)大新(xin)技術(shu)(shu)成(cheng)(cheng)(cheng)果轉化項(xiang)目。公(gong)(gong)司(si)參與研發的(de)“化學藥物(wu)(wu)晶(jing)型關鍵體(ti)系的(de)建(jian)立與應用”榮(rong)獲國(guo)家科(ke)學技術(shu)(shu)進步二等獎。主打(da)產品阿樂?是(shi)北京(jing)(jing)市(shi)(shi)著名(ming)商(shang)標(biao)，上(shang)市(shi)(shi)10余年(nian)，其品質和療效(xiao)受到廣大醫生和患者(zhe)的(de)一(yi)致認可。2016年(nian)阿樂市(shi)(shi)場規模近40億元，占(zhan)中(zhong)國(guo)阿托(tuo)伐他汀市(shi)(shi)場五分(fen)之一(yi)。公(gong)(gong)司(si)以不斷提供(gong)更有(you)效(xiao)的(de)藥物(wu)(wu)，持續(xu)改善人(ren)(ren)類的(de)生命質量為(wei)(wei)企(qi)業使命，自成(cheng)(cheng)(cheng)立以來一(yi)直勤于創新(xin)，勇于探(tan)索，立志成(cheng)(cheng)(cheng)為(wei)(wei)中(zhong)國(guo)心(xin)腦血(xue)管藥物(wu)(wu)市(shi)(shi)場的(de)領(ling)先者(zhe)，成(cheng)(cheng)(cheng)為(wei)(wei)中(zhong)國(guo)最受尊敬(jing)的(de)制(zhi)藥企(qi)業之一(yi)。